Intra-arterial chemotherapy for retinoblastoma: Report no. 2, treatment complications

Archives of Ophthalmology

Volumn 129, Issue 11, 2011, Pages 1407-1415

  Shields, Carol L ^a   Bianciotto, Carlos G ^a   Jabbour, Pascal ^b   Griffin, Gregory C ^b   Ramasubramanian, Aparna ^a   Rosenwasser, Robert ^b   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARBOPLATIN; HEPARIN; MELPHALAN;

ANTICOAGULATION; ARTERY CATHETERIZATION; ARTERY OCCLUSION; ARTICLE; BRANCH RETINAL ARTERY OCCLUSION; CENTRAL RETINA ARTERY OCCLUSION; CHILD; CHOROID GYRATE ATROPHY; CHOROIDAL VASCULAR ATROPHY; CILIA LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; ERYTHEMA; EXTRAOCULAR MUSCLE DYSFUNCTION; EYE MOVEMENT DISORDER; EYELID EDEMA; FEMALE; FLUOROSCOPY; FOREHEAD ERYTHEMA; HUMAN; INFANT; MALE; OPHTHALMIC ARTERY; OPHTHALMIC ARTERY STENOSIS; OPTIC NERVE ATROPHY; ORBIT; ORBITAL CONGESTION; PIGMENT EPITHELIUM; PINEAL BODY TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PTOSIS; RETINA ARTERY OCCLUSION; RETINA DETACHMENT; RETINOBLASTOMA; RETROSPECTIVE STUDY; STROKE; VASCULAR PATENCY; VITREOUS HEMORRHAGE;

ANTINEOPLASTIC AGENTS, ALKYLATING; BLEPHAROPTOSIS; CATHETERIZATION; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHILD; CHILD, PRESCHOOL; EDEMA; EYELID DISEASES; FEMALE; FLUORESCEIN ANGIOGRAPHY; FLUOROSCOPY; HUMANS; INFANT; INJECTIONS, INTRA-ARTERIAL; MALE; MELPHALAN; OCULAR MOTILITY DISORDERS; OPHTHALMIC ARTERY; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES;

EID: 81355133314     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.151     Document Type: Article

References (34)

1. Shields CL, Shields JA. Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey. Clin Experiment Ophthalmol. 2010;38(6):638-643.
2. Shields JA, Shields CL. Management of retinoblastoma. In: Shields JA, Shields CL, eds. Intraocular Tumors: An Atlas and Textbook. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:333-352.
3. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology. 1988;95(11):1583-1587.
4. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol. 2004;138(3):329-337. (Pubitemid 39208559)
5. Shields CL, Shields JA, De Potter P, et al. Plaque radiotherapy in the management of retinoblastoma: use as a primary and secondary treatment. Ophthalmology. 1993;100(2):216-224. (Pubitemid 23056535)
6. Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21(3):203-212.
7. Reese AB, Hyman GA, Tapley ND, Forrest AW. The treatment of retinoblastoma by x-ray and triethylene melamine. AMA Arch Ophthalmol. 1958;60(5):897-906.
8. Kiribuchi M. Retrograde infusion of anti-cancer drugs to ophthalmic artery for intraocular malignant tumors [in Japanese]. Nippon Ganka Gakkai Zasshi. 1966;70(11):1829-1833.
9. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9(2):69-73. (Pubitemid 38619319)
10. Suzuki S, Kaneko A. Management of intraocular retinoblastoma and ocular prognosis. Int J Clin Oncol. 2004;9(1):1-6. (Pubitemid 38470656)
11. Gobin P, Abramson DA. A phase I/II study of intra-arterial (ophthalmic artery) chemotherapy for intraocular retinoblastoma [abstract 60]. J Vasc Interv Radiol. 2008;19(2)(suppl):s24-s25. doi:10.1016/j.jvir.2007.12.067.
12. Gobin P, Marr B, Dunkel I, Brodie S, Abramson D. Intra-arterial chemotherapy (chemosurgery) in the ophthalmic artery for the treatment of retinoblastoma in children: 3 year experience. J Neurointerv Surg. 2009;1(1):77-78. doi:10.1136/jnis.2009.000851n.
13. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115(8):1398- 1404.
14. Abramson DH. Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lecture. Br J Ophthalmol. 2010;94(4):396-399.
15. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117(8):1623-1629.
16. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds [published online June 13, 2011]. Arch Ophthalmol. doi:10.1001/archophthalmol.2011.150.
17. Shields CL, Ramasubramanian A, Rosenwasser R, Shields JA. Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma. Retina. 2009;29(8):1207-1209.
18. Inomata M, Kaneko A. Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay. Jpn J Cancer Res. 1987;78(8):858-868. (Pubitemid 17124771)
19. Mathews J, Goel R, Evans WK, Shamji F, Stewart DJ. Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer. Cancer Chemother Pharmacol. 1997;40(1):19-22. (Pubitemid 27160955)
20. Smith V, Kingston JE, Hungerford JL, et al. Complications of direct intraophthalmic artery melphalan treatment for refractory retinoblastoma. Paper presented at: American Academy of Ophthalmology 2010 Joint Meeting; October 17, 2010; Chicago, IL.
21. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol. 2010;128(3):370-372.
22. Munier FL, Beck-Popovic M, Balmer A, Gaillard MC, Bovey E, Binaghi S. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Retina. 2011;31(3):566-573.
23. Madajewicz S, Chowhan N, Tfayli A, et al. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy. Cancer. 2000;88(10):2350-2356. (Pubitemid 30247136)
24. Grimson BS, Mahaley MS Jr, Dubey HD, Dudka L. Ophthalmic and central nervous system complications following intracarotid BCNU (carmustine). J Clin Neuroophthalmol. 1981;1(4):261-264. (Pubitemid 13046440)
25. Shapiro WR, Green SB, Burger PC, et al. A randomized comparison of intra-arterial vs intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg. 1992;76(5):772-781.
26. Jaffe N, Prudich J, Knapp J, et al. Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate. J Clin Oncol. 1983;1(7):428-431. (Pubitemid 13002960)
27. Winkler K, Bielack S, Delling G, et al. Effect of intraarterial vs intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Cancer. 1990;66(8):1703-1710. (Pubitemid 20381203)
28. Bielack SS, Bieling P, Erttmann R, Winkler K. Intraarterial chemotherapy for osteosarcoma: does the result really justify the effort? In: Humphrey CB, ed. Osteosarcoma in Adolescent and Young Adults. Boston, MA: Kluwer Academic Publishers; 1993:85-92.
29. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96(2):217-222. (Pubitemid 19049464)
30. Shields CL, Shields JA, Baez K, Cater JR, De Potter P. Optic nerve invasion of retinoblastoma: metastatic potential and clinical risk factors. Cancer. 1994;73(3):692-698. (Pubitemid 24046614)
31. Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77(9):544-548. (Pubitemid 23281450)
32. Eagle RC Jr. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med. 2009;133(8):1203-1209.
33. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002;120(7):923-931. (Pubitemid 34755545)
34. Vijayakrishnan R, Shields CL, Ramasubramanian A, Emrich J, Rosenwasser R, Shields JA. Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? Arch Ophthalmol. 2010;128(11):1427-1431.